Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation - PubMed (original) (raw)
. 2002 Jan 15;11(2):115-24.
doi: 10.1093/hmg/11.2.115.
Affiliations
- PMID: 11809720
- DOI: 10.1093/hmg/11.2.115
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation
Mona D Shahbazian et al. Hum Mol Genet. 2002.
Abstract
Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. Previous data have shown that MECP2 RNA is present in all mouse and human tissues tested, but the timing of expression and regional distribution have not been explored. We investigated the spatial and temporal distribution of the MeCP2 protein during mouse and human development. We found that in the adult mouse, MeCP2 is high in the brain, lung and spleen, lower in heart and kidney, and barely detectable in liver, stomach and small intestine. There was no obvious correlation between protein levels and RNA levels, suggesting that translation may be post-transcriptionally regulated by tissue-specific factors. The timing of MeCP2 expression in mouse and human correlated with the maturation of the central nervous system, with the ontogenetically older structures such as the spinal cord and brainstem becoming positive before newer structures such as the hippocampus and cerebral cortex. In the cortex, MeCP2 first appeared in the Cajal-Retzius cells, then in the neurons of the deeper, more mature cortical layers, and finally in the neurons of the more superficial layers. The MeCP2 protein was eventually present in a majority of neurons but was absent from glial cells. Our data suggest that MeCP2 may become abundant only once a neuron has reached a certain degree of maturity, and that this may explain some aspects of the RTT phenotype.
Similar articles
- Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.
Armstrong DD, Deguchi K, Antallfy B. Armstrong DD, et al. J Child Neurol. 2003 Oct;18(10):683-7. doi: 10.1177/08830738030180100601. J Child Neurol. 2003. PMID: 14649549 - Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
Luikenhuis S, Giacometti E, Beard CF, Jaenisch R. Luikenhuis S, et al. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6033-8. doi: 10.1073/pnas.0401626101. Epub 2004 Apr 6. Proc Natl Acad Sci U S A. 2004. PMID: 15069197 Free PMC article. - Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ, Akbarian S, Tudor M, Jaenisch R. Chen RZ, et al. Nat Genet. 2001 Mar;27(3):327-31. doi: 10.1038/85906. Nat Genet. 2001. PMID: 11242118 - The neurobiology of Rett syndrome.
Akbarian S. Akbarian S. Neuroscientist. 2003 Feb;9(1):57-63. doi: 10.1177/1073858402239591. Neuroscientist. 2003. PMID: 12580340 Review. - MeCP2 in neurons: closing in on the causes of Rett syndrome.
Caballero IM, Hendrich B. Caballero IM, et al. Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R19-26. doi: 10.1093/hmg/ddi102. Hum Mol Genet. 2005. PMID: 15809268 Review.
Cited by
- Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes.
Zachariah RM, Olson CO, Ezeonwuka C, Rastegar M. Zachariah RM, et al. PLoS One. 2012;7(11):e49763. doi: 10.1371/journal.pone.0049763. Epub 2012 Nov 19. PLoS One. 2012. PMID: 23185431 Free PMC article. - Variable expression of MECP2, CDKL5, and FMR1 in the human brain: Implications for gene restorative therapies.
Zito A, Lee JT. Zito A, et al. Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2312757121. doi: 10.1073/pnas.2312757121. Epub 2024 Feb 22. Proc Natl Acad Sci U S A. 2024. PMID: 38386709 Free PMC article. - Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome.
Audouard E, Khefif N, Gillet-Legrand B, Nobilleau F, Bouazizi O, Stanga S, Despres G, Alves S, Lamazière A, Cartier N, Piguet F. Audouard E, et al. Pharmaceutics. 2024 Jun 3;16(6):756. doi: 10.3390/pharmaceutics16060756. Pharmaceutics. 2024. PMID: 38931878 Free PMC article. - MECP2 disorders: from the clinic to mice and back.
Lombardi LM, Baker SA, Zoghbi HY. Lombardi LM, et al. J Clin Invest. 2015 Aug 3;125(8):2914-23. doi: 10.1172/JCI78167. Epub 2015 Aug 3. J Clin Invest. 2015. PMID: 26237041 Free PMC article. Review. - BDNF deregulation in Rett syndrome.
Li W, Pozzo-Miller L. Li W, et al. Neuropharmacology. 2014 Jan;76 Pt C(0 0):737-46. doi: 10.1016/j.neuropharm.2013.03.024. Epub 2013 Apr 15. Neuropharmacology. 2014. PMID: 23597512 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases